Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancerKenichi Sugihara, Toshiaki Watanabe, Kei Muro et al.|International Journal of Clinical Oncology|2017Cited by 2.5k
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancerYojiro Hashiguchi, Kei Muro, Yutaka Saitō et al.|International Journal of Clinical Oncology|2019Cited by 2k
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancerKenichi Sugihara, Toshiaki Watanabe, Michio Itabashi et al.|International Journal of Clinical Oncology|2011Cited by 713
Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST StudyHideki Ueno, Masao Tanaka, Jen‐Shi Chen et al.|Journal of Clinical Oncology|2013Cited by 632
Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancerToshiaki Watanabe, Michio Itabashi, Yasuhiro Shimada et al.|International Journal of Clinical Oncology|2015Cited by 600